For those who have not tried our product
the gut can all contribute to diarrhoea symptoms.
Molecules associated with these are potential targets
for Enterosgel to bind and remove from the body, which
could help to alleviate the symptoms of acute diarrhoea
and chronic IBS diarrhoea.
OUR RELIEVE IBS-D TRIAL IS NOW FULLY VIRTUAL!
See Our RELIEVE IBS-D Trial Page for More Details
News of the UK’s first ever virtual IBS trial reaches ministers! Read more here
For those who have not tried
our product
OUR RELIEVE IBS-D TRIAL IS NOW FULLY VIRTUAL!
See Our RELIEVE IBS-D Trial Page
for More Details
News of the UK’s first ever virtual IBS trial reaches ministers! Read more here
SAFE
GENTLE
EFFECTIVE
DRUG-FREE
GENTLE
EFFECTIVE
DRUG-FREE
ENTEROSGEL is an oral suspension indicated for the symptomatic treatment of acute diarrhoea and chronic diarrhoea associated with Irritable Bowel Syndrome (IBS).
ENTEROSGEL is an oral intestinal adsorbent. It is based on organic minerals with adsorption capacity towards some toxic and harmful substances in the gut (e.g. endotoxins, enterotoxins), physically binding them to its surface, reducing stool frequency and duration of diarrhoea. ENTEROSGEL is expelled from the body with the stool, this way eliminating the adsorbed toxins and harmful substances, which can be beneficial for treatment of indicated conditions of acute and chronic diarrhoea.
If you are suffering from IBS-D and would be interested to participate in the research study, please, click here to find out if you are eligible and to find the nearest site. You can contact the research nurse at the participating site for more information.
Eligibility: Male or female aged 18-75, with IBS and diarrhoea symptoms.
The Study Name: Enterosgel in the treatment of Irritable Bowel Syndrome with Diarrhoea (RELIEVE IBS-D).
Study number: GAST34032 | NIHR portfolio.
